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 We implemented a questionnaire-based methodology targeting veterinary field 
practitioners to evaluate clinical and economic impact of Schmallenberg virus in Belgium. 
First suspicious cases were detected as soon as July 2011. The mean cost for individual 
symptomatic treatment was 57 or 82 Euros, in case of fatal outcome or apparent recovery 
respectively. 
 




Since august 2011, veterinarians and farmers reported in lactating cows an unusually 
high frequency of fever, milk-drop and sometimes diarrhoea. This nonspecific clinical picture 
lasted several days before self-resolution (ProMed-Mail, 2011). In November 2011, 
metagenomic analysis performed on pooled blood by the Friedrich-Loeffler-Institut identified 
a novel Orthobunyavirus (family Bunyaviridae), provisionally named Schmallenberg virus 
(SBV). As soon as December 2011, several European countries, including Belgium, reported 
an increase in abortions, still birth and births of deformed lambs, kids and calves, regularly 
associated with positive SBV detection by RTqPCR, in blood or organs of affected animals. 
In 2012 the disease will probably have a lower impact on areas where it circulated in 2011 
due to the very high seroprevalence, up to 90% in Belgian cattle (Garigliany et al, 2012), and 
the resulting self-limitation of virus spread. However, SBV emergence remains a major 
sanitary event in animal health, and its socio-economic impact on livestock is still unclear. 
The main objective of this study was to collect information regarding clinical and 
epidemiological observations from the field, by means of a questionnaire-based methodology, 
targeting field veterinarians. The preliminary results of this survey are presented here, and 
will be used to set up a proper evaluation of the economic losses caused by SBV outbreak in 
Belgium. 
 
Materials and methods 
The anonymous questionnaire was submitted by the professional journal Veterinaria 
and also by mail to large animal practitioners (N=758) in the Walloon region (South part of 
Belgium; Figure 1). An important part of them had only a limited rural activity (a few percent 
of their working time); 350 veterinarians are reported by the Veterinary Professional Union as 
having a significant activity in relation with animal farms. In addition, the questionnaire was 
also mailed to the same veterinarians and, after translation, to the Flemish veterinarians of the 
neighbouring northern region. The answers were gathered from March to May 2012. The 
questionnaire was divided in three parts: data regarding veterinarian’s personal information, 
data associated with involved animal populations and clinical observations. 
Comparison of reported morbidity rates in adult ruminants and their offspring as well as 
treatment cost of the considered species were realised using a non parametric Mann-Whitney 
test (the hypothesis of normality of the distributions could not have been verified). The 
percentage of bovine and small ruminants households tested for SBV versus monitored farms 
has been analysed with a Fisher’s exact test (Petrie and Watson, 2006). 
Results and discussion 
The answer rate was about 8 % (N=27), slightly above the 5% lower threshold 
expected for surveys of this kind (Dufour, 1994). 
Age of the participating veterinarians was homogeneous (ranging from 26 to 65 years), and 
most of them had mainly a rural activity. Participating veterinarians were in charge of a total 
of 1507 herds (1310 cattle, 145 sheep, 12 goat, 10 pig and 30 mixed species herds). The 
following breeds were represented: in cattle, mostly Belgian blue and Holstein; in sheep, 
mostly Texel and in goats, dwarf goats (small herds). 
First suspicious clinical cases were reported as soon as July 2011 (Figure 2) in cattle 
(Holstein), in a farm located in the eastern part of Belgium and near to the German border, 
which is in line with the EFSA report regarding the beginning of the viral circulation 
(European Food Safety Authority, 2012). Clinical signs consisted in milk drop, diarrhoea and 
hyperthermia. Cases of SBV-induced congenital malformations dramatically increased since 
January 2012, involving the three ruminant species. The first official SBV positive case was 
confirmed in sheep the 21
st
 of December 2011 (ProMed-Mail, 2011b). 
In adult cattle, the most frequent clinical signs were milk drop, diarrhoea, fever, 
abortion and dystocia. Mastitis was also reported. Duration of clinical signs was recorded in 7 
cattle herds, and lasted on average 12 days (from 4 to 25). In adult small ruminants, only 
abortion and dystocia were described.  
In cattle offspring, in descending order, the most frequent observations were stiff neck 
or scoliosis, arthrogryposis, weak calf syndrome, stillbirth, hydranencephaly, unspecific 
nervous troubles, and brachygnathism. In lambs, arthrogryposis was first reported, then stiff 
neck or scoliosis, weak lamb syndrome, stillbirth, brachygnathism, then hydranencephaly and 
finally lambs with unspecific nervous troubles. In kids, stillbirth was regularly reported, but 
other clinical signs were rarely described. In addition, none of the participating veterinarian 
had ever been confronted with such a combination of clinical signs before.   
Morbidity rate in adults and newborns are summarized in table 1. It has to be pointed 
out that in adult small ruminants, clinical signs were almost exclusively related to abortions or 
dystocia. In offspring, comparison was only realized between calves and lambs (insufficient 
number of kids); calves had a significantly lower morbidity rate than lambs (Mann-Whitney 
test; p = 0.02). 
By the time of the survey, SBV could only be confirmed by RTqPCR (Table 2). 
Amongst the 27 participating veterinarians, 11 treated the affected animals using a 
symptomatic treatment (non-steroidal anti-inflammatory drugs, antibiotics and B vitamin). 
Only 5 of them reported an improvement in health of the animals. In case of fatal outcome, 
treatment costs reached 57 Euros/animal (ranging from 25 to 80 Euros), whichever the 
considered species. In case of apparent recovery, the treatment costs averaged 82 Euros 
(ranging from 40 to 200 Euros). Treatment costs did not significantly differ between fatal and 
non-fatal cases (Mann-Whitney test, p = 0.91). 
SBV affection does not figure among reportable diseases (Royal Order, 20.11.2009); 
therefore, it is hard to achieve a representative view of the real situation because of the risk of 
under-declaration. Moreover, detection by RTqPCR is limited by the short length of the 
viraemia, ranging from 2 to 5 days in experimentally infected cattle (Hoffmann et al, 2012). 
In contrast with bluetongue disease, the emerging disease caused by SBV was from 
the very beginning characterized by a mild and unspecific affection in adult animals and a 
very large and fast geographic spreading. Retrospective epidemiologic studies would bring to 
light useful data to clarify more accurately spatio-temporal circumstances of SBV emergence 
in Belgium. Participating veterinarians reported the first suspicious cases as soon as July 2011 
in cattle, with a first case along the German border, which reminds of the circumstances of 
BTV emergence, 5 years earlier (Saegerman et al, 2010). The lack of specificity in clinical 
signs seen in adult animals explains the delay between first clinical observations and 
laboratory confirmation. This is supported by a recent EFSA report, which highlights the 
underreporting of SBV cases, easily missed (European Food Safety Authority, 2012b). This 
survey allowed a better characterization of clinical signs in adult ruminants, and as a result 
would help to improve detection of new suspicions in the future. By contrast, clinical picture 
in offspring was highly specific to retain owner’s attention. So far, most of the clinical 
detection was linked to the presence of congenital malformations or still birth. Moreover, the 
interviewed veterinarians never observed a similar clinical picture before SBV emergence. In 
the future it would be interesting to submit a similar questionnaire to farmers in order 
compare their perception with that of practitioners. In addition, some data were gathered 
regarding the treatments used in the field, their (globally poor) efficacy and their costs. 
Conclusion 
Taken altogether, these data suggest that a determinist approach (based on data points) 
would be insufficient to properly characterize socio-economic impact caused by SBV; a 
probabilistic approach (relying on values distribution) would be more suitable. 
SBV biology is currently incompletely characterized, so scenario-based analysis might be of 
the greatest help, improved by other descriptive surveys to be realized in the future. Although 
only a limited number of large animal practitioners were involved in this study, the results of 
the survey bring some new facts that will contribute to set up a proper evaluation of the 
zootechnical and economical losses caused by SBV emergence in Belgium. As these results 
are preliminary, they would warrant an implementation in a larger scale and more detailed 
analysis, including answers of additional practitioners. 
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Table 1. Reported morbidity rate in adult and newborn ruminants 
Type Specie Number of evaluated farms Median (%) Mean   (% - std dev) Minimum (%) Maximum (%) 
Mothers 
Cattle 10 7.5 20.3 – 23.42 3 70 
Sheep 4 5.5 5.5 – 3.7 1 10 
Goat 2 3.5 3.5 – 2.12 2 5 
Offspring 
Cattle 14 2 13.36 – 28.11 1 100 
Sheep 9 10 15.89 – 12.68 3 40 






Table 2. Farms monitored by the veterinarians participating to the survey, with consistent 
SBV clinical cases, and being tested by RTqPCR  
Specie Evaluated farms 
Farms with SBV 
consistent clinical cases 
RTqPCR tested farms 
RTqPCR positive farms, 
amongst tested ones 
Cattle 1310 91 (7)
#
 86 (6,5) 39 (51)* 
Sheep 145 41 (28) 16 (11) 10 (63) 
Goat 12 6 (50) 3 (25) 2 (67) 
#
: In brackets, percentage; *: By the time of the survey, analyses regarding 10 farms were still 
ongoing, so the percentage was calculated on 76 farms only. 
 
Figure 1. Belgian districts where SBV positive cases were observed by the veterinarians 
participating to the survey 
 
 
Figure 2. Number of reported herds with consistent SBV clinical cases in Belgium, 2011-2012 
 
